203 related articles for article (PubMed ID: 26981556)
1. The Impact of Alzheimer's Disease on the Chinese Economy.
Keogh-Brown MR; Jensen HT; Arrighi HM; Smith RD
EBioMedicine; 2016 Feb; 4():184-90. PubMed ID: 26981556
[TBL] [Abstract][Full Text] [Related]
2. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.
Chen S; Kuhn M; Prettner K; Yu F; Yang T; Bärnighausen T; Bloom DE; Wang C
Lancet Glob Health; 2023 Aug; 11(8):e1183-e1193. PubMed ID: 37474226
[TBL] [Abstract][Full Text] [Related]
3. The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
Jia J; Wei C; Chen S; Li F; Tang Y; Qin W; Zhao L; Jin H; Xu H; Wang F; Zhou A; Zuo X; Wu L; Han Y; Han Y; Huang L; Wang Q; Li D; Chu C; Shi L; Gong M; Du Y; Zhang J; Zhang J; Zhou C; Lv J; Lv Y; Xie H; Ji Y; Li F; Yu E; Luo B; Wang Y; Yang S; Qu Q; Guo Q; Liang F; Zhang J; Tan L; Shen L; Zhang K; Zhang J; Peng D; Tang M; Lv P; Fang B; Chu L; Jia L; Gauthier S
Alzheimers Dement; 2018 Apr; 14(4):483-491. PubMed ID: 29433981
[TBL] [Abstract][Full Text] [Related]
4. Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.
Li F; Chen S; Wei C; Jia J
BMC Neurol; 2017 Jan; 17(1):15. PubMed ID: 28122529
[TBL] [Abstract][Full Text] [Related]
5. The US economic and social costs of Alzheimer's disease revisited.
Ernst RL; Hay JW
Am J Public Health; 1994 Aug; 84(8):1261-4. PubMed ID: 8059882
[TBL] [Abstract][Full Text] [Related]
6. 2021 Alzheimer's disease facts and figures.
Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai, China.
Wang G; Cheng Q; Zhang S; Bai L; Zeng J; Cui PJ; Zhang T; Sun ZK; Ren RJ; Deng YL; Xu W; Wang Y; Chen SD
J Alzheimers Dis; 2008 Sep; 15(1):109-15. PubMed ID: 18780971
[TBL] [Abstract][Full Text] [Related]
8. Global economic consequences of selected surgical diseases: a modelling study.
Alkire BC; Shrime MG; Dare AJ; Vincent JR; Meara JG
Lancet Glob Health; 2015 Apr; 3 Suppl 2(Suppl 2):S21-7. PubMed ID: 25926317
[TBL] [Abstract][Full Text] [Related]
9. Macroeconomic costs of the unmet burden of surgical disease in Sierra Leone: a retrospective economic analysis.
Grimes CE; Quaife M; Kamara TB; Lavy CBD; Leather AJM; Bolkan HA
BMJ Open; 2018 Mar; 8(3):e017824. PubMed ID: 29540407
[TBL] [Abstract][Full Text] [Related]
10. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.
Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
Int Psychogeriatr; 2016 Feb; 28(2):247-59. PubMed ID: 26307191
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the impact of China's macroeconomic performance on its trade partners: Evidence based on the GVAR model.
Alam A; Ma J; Hussain I; Fazal R
PLoS One; 2023; 18(1):e0275859. PubMed ID: 36595534
[TBL] [Abstract][Full Text] [Related]
12. The Economic Burden of Alzheimer's Disease in Zhejiang Province.
Yu E; Liao Z; Fan W; Hu W; Tian G; Chen K; Chen S; Hua H; Zheng H; Fang X; Li G; Xie J; Wu S
J Alzheimers Dis; 2021; 80(2):539-553. PubMed ID: 33579844
[TBL] [Abstract][Full Text] [Related]
13. The macroeconomics of dementia--will the world economy get Alzheimer's disease?
Banerjee S
Arch Med Res; 2012 Nov; 43(8):705-9. PubMed ID: 23085453
[TBL] [Abstract][Full Text] [Related]
14. Incorporating health co-benefits into technology pathways to achieve China's 2060 carbon neutrality goal: a modelling study.
Zhang S; An K; Li J; Weng Y; Zhang S; Wang S; Cai W; Wang C; Gong P
Lancet Planet Health; 2021 Nov; 5(11):e808-e817. PubMed ID: 34758346
[TBL] [Abstract][Full Text] [Related]
15. Predicted economic damage from a quick, simple Alzheimer's disease cure.
Norins LC
Med Hypotheses; 2019 Dec; 133():109398. PubMed ID: 31539811
[TBL] [Abstract][Full Text] [Related]
16. Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain.
Darbà J; Kaskens L; Lacey L
Eur J Health Econ; 2015 Nov; 16(8):895-905. PubMed ID: 25348897
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
[TBL] [Abstract][Full Text] [Related]
18. The Potential Impact of Alzheimer's Disease Early Treatment on Societal Costs of Care in Czechia: A Simulation Approach.
Broulikova HM; Sladek V; Arltova M; Cerny J
J Ment Health Policy Econ; 2018 Dec; 21(4):147-161. PubMed ID: 30676992
[TBL] [Abstract][Full Text] [Related]
19. Early identification and treatment of Alzheimer's disease: social and fiscal outcomes.
Weimer DL; Sager MA
Alzheimers Dement; 2009 May; 5(3):215-26. PubMed ID: 19362885
[TBL] [Abstract][Full Text] [Related]
20. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
